Journal of Diabetes and Its Complications
Volume 17, Issue 4 , Pages 218-228, July 2003

The expanding scope of the metabolic syndrome and implications for the management of cardiovascular risk in type 2 diabetes with particular focus on the emerging role of the thiazolidinediones

  • Andrew S. Greenberg

      Affiliations

    • Corresponding Author InformationJean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, 136 Harrison Avenue, Boston, MA 02111, USA. Tel.: +1-617-556-3144

Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA 02111, USA

Division of Endocrinology, Tupper Research Institute, New England Medical Center, Boston, MA 02111, USA

Received 2 October 2002; received in revised form 20 December 2002; accepted 30 December 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1056-8727(03)00002-3

doi:10.1016/S1056-8727(03)00002-3

Journal of Diabetes and Its Complications
Volume 17, Issue 4 , Pages 218-228, July 2003

Article Tools

* Image Usage & Resolution